Differential gender response to respiratory infections and to the protective effect of breast milk in preterm infants

Pediatrics

Volumn 121, Issue 6, 2008, Pages

  Klein, M Inés ^a   Bergel, Eduardo ^b,c   Gibbons, Luz ^b   Coviello, Silvina ^a   Bauer, Gabriela ^d   Benitez, Alicia ^e   Serra, M Elina ^a   Delgado, M Florencia ^a   Melendi, Guillermina A ^a,f   Rodrfguez, Susana ^d   Kleeberger, Steven R ^h   Polack, Fernando P ^a,f,g  

^a Fundacion INFANT   (Argentina)

^b Instituto de Efectividad   (Argentina)

^c UNITED NATIONS DEVELOPMENT PROGRAMME   (United States)

^d HOSPITAL DE PEDIATRÍA PROF DR JUAN P GARRAHAN   (Argentina)

^e Maternidad Sarda   (Argentina)

^f JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^g JOHNS HOPKINS UNIVERSITY   (United States)

^h NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES   (United States)

Author keywords

Breast milk; Gender; Lower respiratory infection; Prematurity; Respiratory syncytial virus

Indexed keywords

ARTICLE; ARTIFICIAL MILK; BREAST FEEDING; BREAST MILK; COHORT ANALYSIS; DISEASE PREDISPOSITION; DISEASE SEVERITY; FEMALE; GENDER; HIGH RISK POPULATION; HOSPITAL READMISSION; HUMAN; HUMORAL IMMUNITY; INFANT; MAJOR CLINICAL STUDY; MALE; PASSIVE IMMUNIZATION; POISSON DISTRIBUTION; PREMATURITY; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROTECTION; RESPIRATORY TRACT INFECTION; SCORING SYSTEM; SEX DIFFERENCE; STATISTICAL MODEL; VERY LOW BIRTH WEIGHT; NEWBORN;

BREAST FEEDING; FEMALE; HUMANS; INFANT; INFANT, NEWBORN; INFANT, PREMATURE, DISEASES; MALE; PROSPECTIVE STUDIES; RESPIRATORY TRACT INFECTIONS; SEX FACTORS;

EID: 48949088392     PISSN: 00314005     EISSN: 10984275     Source Type: Journal    
DOI: 10.1542/peds.2007-1757     Document Type: Article

References (42)

1. Kusel MN, De Klerk NH, Holt PG, Kebadze T, Johnston SL, Sly PD. Role of respiratory viruses in acute upper and lower respiratory tract illness in the first year of life: a birth cohort study. Pediatr Infect Dis J. 2006;25(8):680-686
2. Collins PL, Chanock RM, Murphy BR. Respiratory syncytial virus. In: Kinpe DM, Howley PM, eds. Fields Virology. Philadelphia: Lippincott; 2001;45:1443-1485
3. Law BJ, Langley JM, Allen U, et al. The Pediatric Investigators Collaborative Network on Infections in Canada study of predictors of hospitalization for respiratory syncytial virus infection for infants born at 33 through 35 completed weeks of gestation. Pediatr Infect Dis J. 2004;23(9):806-814
4. Simoes EA. Environmental and demographic risk factors for respiratory syncytial virus lower respiratory tract disease. J Pe- diatr. 2003;143(5 suppl):S118-S126
5. Klein MI, Coviello S, Bauer G, et al. The impact of infection with human metapneumovirus and other respiratory viruses in young infants and children at high risk for severe pulmonary disease. J Infect Dis. 2006;193(11):1544-1551
6. Poland GA, Rottinghaus ST, Jacobson RM. Influenza vaccines: a review and rationale for use in developed and underdeveloped countries. Vaccine. 2001;19(17-19):2216-2220
7. Fariña D, Rodŕiguez S, Bauer G, et al. Respiratory syncytial virus prophylaxis: cost-effective analysis in Argentina. Pediatr Infect Dis J. 2002;21(4):287-291
8. López-Alarcón M, Villalpando S, Fajardo A. Breastfeeding lowers the frequency and duration of acute respiratory infection and diarrhea in infants under six months of age. J Nutr. 1997; 127(3):436-443
9. Wright AL, Bauer M, Naylor A, Sutcliffe E, Clark L. Increasing breastfeeding rates to reduce infant illness at the community level. Pediatrics. 1998;101(5):837-844
10. Elder DE, Hagan R, Evans SF, Benninger AR, French NP. Hospital admissions in the first year of life in very premature infants. J Paediatr Child Health. 1999;35(2):145-150
11. Van de Perre P. Transfer of antibody via mother's milk. Vaccine. 2003;21(24):3374-3376
12. Fishaut M. Murphy D, Neifert M, Mcintosh K, Ogra PL. Broncho-mammary axis in the immune response to respiratory syncytial virus. J Pediatr. 1981;99(2):186-191
13. Hanson LA, Korotkova M. The role of breastfeeding in prevention of neonatal infection. Semin Neonatol. 2002;7(4):275-281
14. Levay PF, Viljoen M. Lactoferrin: a general review. Haematologica. 1995;80(3):252-267
15. Ryan-Poirier KA, Kawaoka Y. α2-Macroglobulin is the major neutralizing inhibitor of influenza A virus in pig serum. Virology. 1993;193(2):974-976
16. Buescher ES, McWilliams-Koeppen P. Soluble tumor necrosis factor-alpha (TNF-alpha) receptors in human colostrums and milk bind TNF-alpha and neutralize TNF-alpha bioactivity. Pediatr Res. 1998;44(1):37-42
17. Sinha A, Madden J, Ross-Degnan D, Soumerai S, Platt R. Reduced risk of neonatal respiratory infections among breastfed girls but not boys. Pediatrics. 2003;112(4). Available at: www.pediatrics.org/cgi/content/ full/112/4/e303
18. Wright AL, Holberg CJ, Martinez FD, Morgan WJ, Taussig LM. Breast feeding and lower respiratory tract illness in the first year of life. Group Health Medical Associates. BMJ. 1989; 299(6705):946-949
19. Vinther T, Helsing E. Breastfeeding: How to Support Success-A Practical Guide for Health Care Workers. Copnehagen, Denmark: World Health Organization, Regional Office for Europe; 1997
20. Groothuis JR, Simoes EA, Levin MJ, et al. Prophylactic administration of respiratory syncytial virus immune globulin to high-risk infants and young children. The Respiratory Syncy- tial Virus Immune Globulin Study Group. N Engl J Med. 1993; 329(21):1524-1530
21. Laham FR, Israele V, Casellas JM, et al. Differential production of inflammatory cytokines between primary infection with human metapneumovirus and other common respiratory viruses of infancy. J Infect Dis. 2004;189(11):2047-2056
22. Ehrenkranz RA, Walsh MC, Vohr BR, et al. Validation of the Neonatal Institutes of Health consensus definition of bronchopulmonary dysplasia. Pediatrics. 2005;116(6):1353-1360
23. Hosmer DW, Lemeshow S: Applied Logistic Regression. 2nd ed. New York, NY: John Wiley & Sons; 2000
24. Zou G. A modified Poisson regression approach to prospective studies with binary data. Am J Epidemiol. 2004;159(7):702-706
25. Andersen PK. Survival analysis 1982-1991: the second decade of the proportional hazards regression model. Stat Med. 1991; 10(12):1931-1941
26. Mahei CD, Chevret S. Estimation of the treatment effect in a clinical trial when recurrent events define the endpoint. Stat Med. 1999;18(14):1821-1829
27. Greenberg DP, Walker RE, Lee MS, et al. A bovine parainfluenza virus type 3 vaccine is safe and immunogenic in early infancy. J Infect Dis. 2005;191(7):1116-1122
28. Karron RA, Wright PF, Belshe RB, et al. Identification of a recombinant live attenuated respiratory syncytial virus vaccine candidate that is highly attenuated in infants. J Infect Dis. 2005;191(7):1093-1104
29. Belshe RB, Newman FK, Anderson EL, et al. Evaluation of combined live, attenuated respiratory syncytial virus and para- influenza 3 virus vaccines in infants and young children. J Infect Dis. 2004;190(12):2096-2103
30. Cox NJ, Bridges CB. Inactivated and live attenuated influenza vaccines in young children: how do they compare? N Engl J Med. 2007;356(7):729-731
31. Thomas MR, Marston L, Rafferty GF, et al. Respiratory function of very prematurely born infants at follow up: influence of sex. Arch Dis Child Fetal Neonatal Ed. 2006;91(3): F197-F201
32. Garenne M, Leroy O, Beau JP, Sene I. Child mortality after high-titre measles vaccines: prospective study in Senegal. Lancet. 1991;338(8772):903-907
33. Holt EA, Moulton LH, Siberry GK, Halsey NA. Differential mortality by measles vaccine titer and sex. J Infect Dis. 1993; 168(5):1087-1096
34. Hewlett EL. Bordetella species. In: Mandell D, Bennett JE, Dolin R, eds. Mandell, Douglas and Bennett's Principles and Practice of Infectious Diseases. Livingstone, NY: Churchill; 1995: 2078-2083
35. Griffin DE, Ward BJ. Differential CD4 T cell activation in measles. J Infect Dis. 1993;168(2):275-281
36. Ryan EJ, Nilsson L, Kjellman N, Gothefors L, Mills KH. Booster immunization of children with an acellular pertussis vaccine enhances Th2 cytokine production and serum IgE responses against pertussis toxin but not against common allergens. Clin Exp Immunol. 2000;121(2):193-200
37. Choi EH, Lee HJ, Yoo T, Chanock SJ. A common haplotype of interleukin-4 gene IL4 is associated with severe respiratory syncytial virus disease in Korean children. J Infect Dis. 2002; 186(9):1207-1211
38. Puthothu B, Krueger M, Forster J, Heinzmann A. Association between severe respiratory syncytial virus infection and IL13/ IL4 haplotypes. J Infect Dis. 2006;193(3):438-441
39. Prescott SL, Macaubas C, Smallacombe T, Holt BJ, Sly PD, Holt PG. Development of allergen-specific T-cell memory in atopic and normal children. Lancet. 1999;353(9148):196-200
40. Roine I, Fernandez JA, Vasquez A, Caneo M. Breastfeeding reduces immune activation in primary respiratory syncytial virus infection. Eur Cytokine Netw. 2005;16(3):206-210
41. Chellakooty M, Juul A, Boisen KA, et al. A prospective study of serum insulin-like growth factor I (IGF-I) and IGF-binding protein-3 in 942 healthy infants: associations with birth weight, gender, growth velocity, and breastfeeding. J Clin En- docrinol Metab. 2006;91(3):820-826
42. Kramer MS. Does breastfeeding help protect against atopic disease? Biology, methodology, and a golden jubilee of controversy. J Pediatr. 1988;112(2):181-190